Pcsk9 is upregulated in patients with hypertension and hypercholesterolemia and is linearly associated with a larger fraction of an atheroma containing a necrotic core fraction in patients, but is not associated with the presence of a thin cap fibrous atheroma, overall plaque burden or plaque volume [21]. Here, PCSK9 is linked to hypertensive disorder.